JURVIGO
Live / Registered — Registered (as of 06 Apr 2021)
What this means for you
Registered since 06 Apr 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88149295
- Registration number
- 6311618
- Mark type
- Stylized text
- Filed
- 10 Oct 2018
- Published for opposition
- 19 Jan 2021
- Registered
- 06 Apr 2021
- Attorney of record
- Daniel R. Mello
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation
- Class 041 — Education and entertainment services: Educational services, namely, lectures, seminars, training and classes in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; education, namely, lectures, seminars, classes and training in the use of pharmaceuticals for cardiac and other health issues
- Class 042 — Scientific and technological services: Medical and pharmaceutical research for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease research, namely, single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation for medical research purposes; conducting clinical trials for others
- Class 044 — Medical, beauty and agricultural services: Medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes
Owner
- Mezzion Pharma Co., Ltd., Seoul, KR
- Mezzion Pharma Co., Ltd., Seoul, KR
- Mezzion Pharma Co., Ltd., Seoul, KR
Prosecution history
- 23 Aug 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Aug 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 23 Aug 2024 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 23 Aug 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Aug 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 May 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 May 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 29 May 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 May 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 May 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 May 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
- 19 Jan 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Jan 2021 — PUBLISHED FOR OPPOSITION
- 30 Dec 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED